These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 10811315

  • 1. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S, McHutchison J.
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract] [Full Text] [Related]

  • 2. Ribavirin approved with a big fat price.
    Falkenberg J.
    Notes Undergr; 1998 May; (No 37):10-1. PubMed ID: 11365818
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C: new treatment overview.
    Stoia J.
    AIDS Treat News; 1998 Sep 04; (302):5-6. PubMed ID: 11365763
    [Abstract] [Full Text] [Related]

  • 4. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M, Vilella Martorell A, Carral Martínez M, Jimeno Beltrán T, Román Ruiz del Moral Y, Pradas Guerrero C, Gili Planas M, Roca Bennasar M.
    Gastroenterol Hepatol; 2011 Apr 04; 34(4):307-8. PubMed ID: 21376422
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2008 Aug 04; 80(8):1363-9. PubMed ID: 18551610
    [Abstract] [Full Text] [Related]

  • 6. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG.
    Hepatology; 1997 Aug 04; 26(2):505-6. PubMed ID: 9252167
    [No Abstract] [Full Text] [Related]

  • 7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct 04; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C in 2012.
    Lemon M.
    S D Med; 2012 Nov 04; 65(11):432-3. PubMed ID: 23189411
    [No Abstract] [Full Text] [Related]

  • 9. The treatment of hepatitis C: history, presence and future.
    Vrolijk JM, de Knegt RJ, Veldt BJ, Orlent H, Schalm SW.
    Neth J Med; 2004 Mar 04; 62(3):76-82. PubMed ID: 15209471
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar 04; 10(1):2-3. PubMed ID: 11365430
    [Abstract] [Full Text] [Related]

  • 11. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M, Fernández Lucas M, Echarri R, Teruel JL, Alarcón C, Merino JL, Ortuño J.
    Nefrologia; 2004 Mar 04; 24 Suppl 3():39-42. PubMed ID: 15219067
    [Abstract] [Full Text] [Related]

  • 12. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S, Brillet R, Lázaro E, Hézode C, Pawlotsky JM.
    J Virol; 2007 Jul 04; 81(14):7732-41. PubMed ID: 17494069
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A, Yong JF, Zulkifli HI, Jamal R.
    Med J Malaysia; 2002 Sep 04; 57(3):353-6. PubMed ID: 12440276
    [Abstract] [Full Text] [Related]

  • 14. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.
    Di Martino V, Boudjema H, Delacour T, Cazier A, Caron C, Coutarel P, Dumouchel P, Cadranel JF.
    Clin Infect Dis; 2001 Mar 01; 32(5):830-1. PubMed ID: 11229855
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic hepatitis C: present and future].
    Hezode C, Dhumeaux D.
    Gastroenterol Clin Biol; 2000 May 01; 24(5):533-5. PubMed ID: 10891741
    [No Abstract] [Full Text] [Related]

  • 16. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J.
    Hepatology; 2002 Nov 01; 36(5):1253-8. PubMed ID: 12395337
    [Abstract] [Full Text] [Related]

  • 17. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C.
    Khalili M, Denham C, Perrillo R.
    Am J Gastroenterol; 2000 May 01; 95(5):1284-9. PubMed ID: 10811340
    [Abstract] [Full Text] [Related]

  • 18. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P.
    J Gastroenterol Hepatol; 2005 May 01; 20(5):669-70. PubMed ID: 15853976
    [No Abstract] [Full Text] [Related]

  • 19. [Retreatment of patients with chronic hepatitis C].
    Ostojić R.
    Acta Med Croatica; 2005 May 01; 59(5):447-51. PubMed ID: 16381242
    [Abstract] [Full Text] [Related]

  • 20. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
    Boulestin A, Sandres-Saune K, Alric L, Pipy B, Dubois M, Vinel JP, Izopet J.
    Antivir Ther; 2005 May 01; 10(4):499-504. PubMed ID: 16038475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.